RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com

Similar
Filing Names

Laboratoire Francais Du Fractionnement Et Des Biotechnologies
Laboratoire Francais Du Fractionnement Et Des Biotechnologies S a
Laboratoire Francais Du Fractionnement Et Des Biotechnologies Sa
  

Laboratoire Francais Du Fractionnement Et Des Biotechnologies patents

Recent patent applications related to Laboratoire Francais Du Fractionnement Et Des Biotechnologies. Laboratoire Francais Du Fractionnement Et Des Biotechnologies is listed as an Agent/Assignee. Note: Laboratoire Francais Du Fractionnement Et Des Biotechnologies may have other listings under different names/spellings. We're not affiliated with Laboratoire Francais Du Fractionnement Et Des Biotechnologies, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "L" | Laboratoire Francais Du Fractionnement Et Des Biotechnologies-related inventors




Date Laboratoire Francais Du Fractionnement Et Des Biotechnologies patents (updated weekly) - BOOKMARK this page
06/15/17Albumin-purification method comprising a nanofiltration step, solution, and composition for therapeutic use containing the same
06/08/17Packaging for a medicament used for innovative therapy
03/23/17Copolymers of formula (i) and uses
03/16/17Method for preparing human plasma proteins
12/01/16Immunoglobulin against the anthrax toxin
09/22/16Factor vii composition
06/30/16Use of monoclonal antibodies for the treatment of inflammation and bacterial infections
06/23/16Gla-domainless factor x
06/16/16Affinity chromatography matrix
06/02/16Transgenic factor vii having a specific n-glycosylation and substantially homogenous isoelectric point
05/19/16Method for purifying active gla-domain coagulation proteins
04/21/16Treatment of bleeding with low half-life fibrinogen
03/31/16Method for inactivating a prion protein
03/03/16Cytotoxic antibody directed against type b lymphoid hematopoietic proliferations
02/18/16Novel medicaments comprising an antibody composition enriched with predominant charge isoform
02/04/16Concentrated human immunoglobulin composition
01/28/16Method for preparing a concentrate of factor xi
01/14/16Method for purifying or detecting a target protein
01/07/16Cetuximab with modified glycosylation and uses thereof
12/31/15Proteins with modified glycosylation and methods of production thereof
12/24/15Highly galactosylated anti-her2 antibodies and uses thereof
12/03/15Use of antidotes to coagulation inhibitors indicated in the prevention or treatment of thromboembolic pathologies
10/29/15Use of adcc-optimized antibodies for treating weak patients
10/15/15Combination of anti-cd20 antibody and pi3 kinase selective inhibitor
09/24/15Monoclonal antibodies with enhanced adcc function
08/13/15Syringe containing a composition, especially a pharmaceutical composition, comprising immunoglobins, the production thereof and use of same
08/06/15Factor vii composition
06/25/15Method for purifying transgenic factor vii
06/04/15Monoclonal antibodies with enhanced adcc function
03/12/15Transcription units and the use thereof in expression vectors
11/06/14Anti-fh aptamers, producing same, and uses thereof
08/07/14Pharmaceutical composition comprising factor vii encapsulated in micelles
06/12/14Monoclonal antibodies with enhanced adcc function
06/05/14Process for separating proteins fibrinogen, factor xiii and biological glue from a solubilized plasma fraction and for preparing lyophilised concentrates of said proteins
05/29/14Process for separating proteins fibrinogen, factor xiii and biological glue from a solubilized plasma fraction and for preparing lyophilised concentrates of said proteins
05/22/14Method for preparing a concentrate of polyvalent immunoglobulin
02/13/14Method for preparing a depleted plasma material consisting of one or more thrombogenic factors
02/13/14Method for preparing a concentrate of factor xi
12/05/13Glycols as pathogen inactivating agents
10/03/13Serum amyloid p protein
08/22/13Stabilized human immunoglobulin composition
08/08/13Stabilising formulation for immunoglobulin g compositions in liquid form and in lyophilised form
05/16/13Concentrated human immunoglobulin composition
02/28/13Method for measuring igg-mediated complement activation
02/16/12Use of an immunoglobulin g (igg) concentrate depleted of anti-a and anti-b antibodies for treating neonatal jaundice caused by maternal-foetal incompatibility with respect to the abo system
12/29/11Immunoglobulin g composition
03/10/11Method for treating cancer using monoclonal antibodies
03/10/11Method for treating infectious disease using monoclonal antibodies
03/03/11Method for treating idiopathic thrombocytopenic purpura using monoclonal antibodies
12/23/10Cytokine production-inducing antibody
03/26/09Treatment of pathologies which escape the immune response, using optimized antibodies
03/26/09Synthetic and standardized prion infectuous material, and uses thereof as an injecting inoculum
02/26/09Cytotoxic antibody directed against type b lymphoid hematopoietic proliferations
04/12/12Prothrombic complex composition
06/13/13Thrombin-free biological adhesive and use thereof as a medicament







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Laboratoire Francais Du Fractionnement Et Des Biotechnologies in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Laboratoire Francais Du Fractionnement Et Des Biotechnologies with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';